(Q40632683)

22 September 2017

title

A rational framework for decision making by the National Institute For Clinical Excellence (NICE). (English)

1 reference

22 September 2017

1 reference

2

Mark Sculpher

1 reference

22 September 2017

1

Karl Claxton

1 reference

22 September 2017

Michael Drummond

3

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

22 September 2017

1 reference

22 September 2017

volume

360

1 reference

22 September 2017

issue

9334

1 reference

22 September 2017

page(s)

711-715

1 reference

Formulary submission guidelines for Blue Cross and Blue Shield of Colorado and Nevada. Structure, application and manufacturer responsibilities.

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909832-X

7 January 2021

Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909832-X

7 January 2021

The iterative use of economic evaluation as part of the process of health technology assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909832-X

7 January 2021

The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909832-X

7 January 2021

An introduction to Markov modelling for economic evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909832-X

7 January 2021

Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909832-X

7 January 2021

Markov models in medical decision making: a practical guide.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909832-X

7 January 2021

Cytological screening and management of abnormalities in prevention of cervical cancer: an overview with stochastic modelling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909832-X

7 January 2021

Probabilistic analysis of decision trees using Monte Carlo simulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909832-X

7 January 2021

Bayesian value-of-information analysis. An application to a policy model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909832-X

7 January 2021

An economic approach to clinical trial design and research priority-setting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909832-X

7 January 2021

Sensitivity analysis and the expected value of perfect information

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909832-X

7 January 2021

The FDA's regulation of health economic information

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909832-X

7 January 2021

10.1016/S0140-6736(02)09832-X

Identifiers

DOI

1 reference

22 September 2017

1 reference